Your browser doesn't support javascript.
loading
Functional characterization of miR-708 microRNA in telomerase positive and negative human cancer cells.
Kaul, Zeenia; Cheung, Caroline T Y; Bhargava, Priyanshu; Sari, Anissa Notifa; Yu, Yue; Huifu, He; Bid, Hemant; Henson, Jeremy D; Groden, Joanna; Reddel, Roger R; Kaul, Sunil C; Wadhwa, Renu.
Afiliação
  • Kaul Z; Children's Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, 2145, Australia.
  • Cheung CTY; AIST-INDIA DAILAB, DBT-AIST International Center for Translational & Environmental Research (DAICENTER), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba, 305-8565, Japan.
  • Bhargava P; The Ohio State Medical Comprehensive Cancer Center, 460 W 12th Avenue, Columbus, OH, 43210, USA.
  • Sari AN; AIST-INDIA DAILAB, DBT-AIST International Center for Translational & Environmental Research (DAICENTER), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba, 305-8565, Japan.
  • Yu Y; AIST-INDIA DAILAB, DBT-AIST International Center for Translational & Environmental Research (DAICENTER), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba, 305-8565, Japan.
  • Huifu H; AIST-INDIA DAILAB, DBT-AIST International Center for Translational & Environmental Research (DAICENTER), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba, 305-8565, Japan.
  • Bid H; AIST-INDIA DAILAB, DBT-AIST International Center for Translational & Environmental Research (DAICENTER), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba, 305-8565, Japan.
  • Henson JD; Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 1-8-31, Ikeda, Osaka, 563-8577, Japan.
  • Groden J; AIST-INDIA DAILAB, DBT-AIST International Center for Translational & Environmental Research (DAICENTER), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba, 305-8565, Japan.
  • Reddel RR; Life Sciences Institute, University of Michigan, Ann Arbor, MI, 48109, USA.
  • Kaul SC; Cancer Cell Immortality Group, Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, 2052, Australia.
  • Wadhwa R; The Ohio State Medical Comprehensive Cancer Center, 460 W 12th Avenue, Columbus, OH, 43210, USA.
Sci Rep ; 11(1): 17052, 2021 08 23.
Article em En | MEDLINE | ID: mdl-34426596
Activation of a telomere length maintenance mechanism (TMM), including telomerase and alternative lengthening of telomeres (ALT), is essential for replicative immortality of tumor cells, although its regulatory mechanisms are incompletely understood. We conducted a microRNA (miRNA) microarray analysis on isogenic telomerase positive (TEP) and ALT cancer cell lines. Amongst nine miRNAs that showed difference in their expression in TEP and ALT cancer cells in array analysis, miR-708 was selected for further analysis since it was consistently highly expressed in a large panel of ALT cells. miR-708 in TEP and ALT cancer cells was not correlated with C-circle levels, an established feature of ALT cells. Its overexpression induced suppression of cell migration, invasion, and angiogenesis in both TEP and ALT cells, although cell proliferation was inhibited only in TEP cells suggesting that ALT cells may have acquired the ability to escape inhibition of cell proliferation by sustained miR-708 overexpression. Further, cell proliferation regulation in TEP cells by miR708 appears to be through the CARF-p53 pathway. We demonstrate here that miR-708 (i) is the first miRNA shown to be differentially regulated in TEP and ALT cancer cells, (ii) possesses tumor suppressor function, and (iii) deregulates CARF and p21WAF1-mediated signaling to limit proliferation in TEP cells.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Telomerase / MicroRNAs / Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Telomerase / MicroRNAs / Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article